M. BEKTAŞ And M. İKBAL KILIÇ, "Predictors of Mortality in Severe and Critical COVID-19 Patients Receiving High Dose Intravenous Anakinra (Yüksek Doz İntravenöz Anakinra Alan Ciddi ve Kritik COVİD-19 Hastalarında Mortalite Öngördürücüleri)," JOURNAL OF IMMUNOLOGY AND CLINICAL MICROBIOLOGY , vol.8, no.1, pp.7-16, 2023
BEKTAŞ, M. And İKBAL KILIÇ, M. 2023. Predictors of Mortality in Severe and Critical COVID-19 Patients Receiving High Dose Intravenous Anakinra (Yüksek Doz İntravenöz Anakinra Alan Ciddi ve Kritik COVİD-19 Hastalarında Mortalite Öngördürücüleri). JOURNAL OF IMMUNOLOGY AND CLINICAL MICROBIOLOGY , vol.8, no.1 , 7-16.
BEKTAŞ, M., & İKBAL KILIÇ, M., (2023). Predictors of Mortality in Severe and Critical COVID-19 Patients Receiving High Dose Intravenous Anakinra (Yüksek Doz İntravenöz Anakinra Alan Ciddi ve Kritik COVİD-19 Hastalarında Mortalite Öngördürücüleri). JOURNAL OF IMMUNOLOGY AND CLINICAL MICROBIOLOGY , vol.8, no.1, 7-16.
BEKTAŞ, Murat, And MUHAMMED İKBAL KILIÇ. "Predictors of Mortality in Severe and Critical COVID-19 Patients Receiving High Dose Intravenous Anakinra (Yüksek Doz İntravenöz Anakinra Alan Ciddi ve Kritik COVİD-19 Hastalarında Mortalite Öngördürücüleri)," JOURNAL OF IMMUNOLOGY AND CLINICAL MICROBIOLOGY , vol.8, no.1, 7-16, 2023
BEKTAŞ, Murat And İKBAL KILIÇ, MUHAMMED İ. . "Predictors of Mortality in Severe and Critical COVID-19 Patients Receiving High Dose Intravenous Anakinra (Yüksek Doz İntravenöz Anakinra Alan Ciddi ve Kritik COVİD-19 Hastalarında Mortalite Öngördürücüleri)." JOURNAL OF IMMUNOLOGY AND CLINICAL MICROBIOLOGY , vol.8, no.1, pp.7-16, 2023
BEKTAŞ, M. And İKBAL KILIÇ, M. (2023) . "Predictors of Mortality in Severe and Critical COVID-19 Patients Receiving High Dose Intravenous Anakinra (Yüksek Doz İntravenöz Anakinra Alan Ciddi ve Kritik COVİD-19 Hastalarında Mortalite Öngördürücüleri)." JOURNAL OF IMMUNOLOGY AND CLINICAL MICROBIOLOGY , vol.8, no.1, pp.7-16.
@article{article, author={Murat BEKTAŞ And author={MUHAMMED İKBAL KILIÇ}, title={Predictors of Mortality in Severe and Critical COVID-19 Patients Receiving High Dose Intravenous Anakinra (Yüksek Doz İntravenöz Anakinra Alan Ciddi ve Kritik COVİD-19 Hastalarında Mortalite Öngördürücüleri)}, journal={JOURNAL OF IMMUNOLOGY AND CLINICAL MICROBIOLOGY}, year=2023, pages={7-16} }